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ABSTRACT 
 
Bronchopulmonary dysplasia (BPD) is a chronic lung disease that affects preterm infants. 
Increased levels of inflammatory mediators in the amniotic fluid and in the lungs of preterm 
infants are associated with the development of BPD. It has been shown that infant transgenic 
mice that express interleukin (IL)-1β in the lung epithelium from approximately embryonal 
day 14 (pseudoglandular stage of lung development) develop a pulmonary injury that 
resembles BPD, supporting the idea that inflammation plays an important role in the 
pathogenesis of BPD. The mechanisms by which inflammation causes lung injury have not 
been identified. 
 
The aim of this thesis was to define mechanisms by which perinatal inflammatory lung injury 
develops by using transgenic mice that express IL-1β in the lung epithelium in an inducible 
manner.  
 
The β6 integrin subunit has previously been shown to be involved in the progression of 
pulmonary diseases in adult mice. To investigate the involvement of the β6 integrin subunit in 
IL-1β-induced lung disease in the neonate, lung development of IL-1β-expressing mice 
lacking the β6 integrin subunit were compared with that of IL-1β-expressing mice with wild-
type β6 loci. Absence of the β6 integrin subunit alleviated the IL-1β-induced lung injury, as 
demonstrated by smaller alveoli, thinner alveolar walls, and a milder lung inflammation than 
IL-1β-expressing mice with wild-type β6 integrin loci. The results suggest that the β6 integrin 
subunit plays a role in the development of neonatal lung disease.  
 
Increased levels of matrix metalloproteinase (MMP)-9 and an imbalance between proteases 
and antiproteases in the lungs of infants and animals developing BPD have led to the 
hypothesis that MMP-9 may be involved in the pathogenesis of the disease. No differences in 
lung histology were detected between mice with wild-type MMP-9 loci and mice with null 
MMP-9 loci, implying a non-essential role of MMP-9 during lung development. However, IL-
1β caused a more severe alveolar hypoplasia in mice deficient in MMP-9 than in MMP-9 
wild-type mice, suggesting that MMP-9 may have a protective role during inflammatory lung 
injury. 
 
A short-term exposure of IL-1 has been shown to accelerate development of the surfactant 
system in fetal rabbits and lambs. Using transgenic mice where the expression of IL-1β is 
restricted to the distal lung epithelium, the effects on lung development and function of 
chronic prenatal IL-1β production were studied. Distal lung expression of IL-1β disrupted 
acinar bud formation prior to birth and decreased the expression of the important surfactant 
proteins SP-B and SP-C. The 100% mortality observed among the IL-1β-expressing mice was 
probably due to the inflammation-induced structural changes and to deficient surfactant 
function. The results suggest that an early and continuous inflammatory stimulus in the distal 
lung epithelium causes severe lung injury and disrupts surfactant production. 
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INTRODUCTION 
 
Structure of the lung 
The main function of the lung is to transport oxygen from the air into the bloodstream and to 
release carbon dioxide from the bloodstream to the atmosphere. The gas exchange is 
performed by epithelial cells within the thin alveolar-capillary membrane in the peripheral 
lung (Marieb, 2001). The lungs of humans, as well as mice, are composed of five lobes. In 
humans, the left lung is divided into two lobes and the right lung into three, whereas the left 
lung of the mouse forms a single lobe and the right lung is subdivided into four lobes 
(superior, middle, postcaval, and inferior) (Braun et al., 2004).  
 
The respiratory system consists of conductive and respiratory zones. The conductive zone 
contains the trachea, the bronchi, the bronchioles, and the terminal bronchioles. The airway 
epithelium contains ciliated cells, basal cells, and mucus-producing goblet cells. The 
bronchiolar epithelium contains non-ciliated Clara cells that secrete Clara cells secretory 
protein (CCSP). The principal roles of the conductive zone are to transfer air towards the site 
of gas exchange, to humidify and warm the inhaled air, and to remove irritants such as dust 
and bacteria to protect the airway from injury. The respiratory zone contains the respiratory 
bronchioles, the alveolar ducts and alveoli, which are the actual sites of gas exchange 
(Marieb, 2001). 
 
The alveolar epithelium consists mainly of thin squamous alveolar type I cells, which together 
with the closely situated capillary endothelial cells form the thin alveolar-capillary membrane 
that is responsible for gas exchange. The alveolar epithelium also consists of cuboidal type II 
epithelial cells that secrete surfactant (Marieb, 2001). When the alveolar epithelium is 
exposed to toxic agents that lead to destruction of the type I epithelial cells, type II epithelial 
cells can proliferate and may act as precursor cells for type I cells (Adamson and Bowden, 
1974; Mendelson, 2000). In addition to specialized epithelial cells, the alveoli contains 
alveolar macrophages that internalize and destroy foreign material, such as infectious 
microorganims, and clear the alveoli from damaged or old epithelial cells (Marieb, 2001).  
 
Lung development 
During the development of the lung, branching morphogenesis occurs to increase the lung 
surface area to provide sufficient respiratory function after birth. The development of the 
mammalian lung can be divided into five stages; the embryonic, the pseudoglandular, the 
canalicular, the saccular, and the alveolar stage (Table 1) (Burri, 2006; Maeda et al., 2007). 
 
Table 1. Timing of the developmental stages in human and mouse 
Stage Human (weeks) 
Term 40 weeks 
Mouse (days) 
Term 19 days 
Embryonic 3 – 7 9 – 12 
Pseudoglandular 5 – 17 12 – 16 
Canalicular 16 – 26 16 – 17 
Saccular 24 – 38 17 – PN 5 
Alveolar 36 – (1-2 years) PN 4 – 28 
PN = postnatal day 
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The embryonic stage 
The embryonic stage of lung development begins with the formation of an outgrowth from the 
primitive foregut endodermal epithelium. The outgrowth separates from the primitive 
esophagus to form the tracheal rudiment and gives rise to two primary bronchial buds, which 
branch into the surrounding mesenchyme to divide the lung into the five lobes. The 
pulmonary vessels arise from the aortic arches and the left atrium and grow into the 
mesenchyme along the developing airways (Jobe, 2002; Maeda et al., 2007). 
 
The pseudoglandular stage 
During the pseudoglandular stage, the branching of airways and vascular system continues 
and forms the bronchial tree with conductive airways, terminal bronchioles, and primitive 
acinar structures. Differentiation of epithelial cells results in the appearance of ciliated cells, 
goblet cells and basal cells in the main bronchi (Jobe, 2002). The expression of surfactant 
proteins during the pseudoglandular stage (Khoor et al., 1993; Khoor et al., 1994; Wert et al., 
1993) indicates epithelial cell differentiation in the primitive acinar structures during this 
stage of lung development. The vascular system develops along the bronchial and bronchiolar 
tubules (Jobe, 2002).  
 
The canalicular stage 
The respiratory structures undergo further subdivision and widening to form clusters of acinar 
tubules and buds during the canalicular stage. The epithelial differentiation is concentrated in 
the peripheral part of the respiratory tree, and this is accompanied by the growth and 
development of intra-acinar double capillary network in close relation with the epithelium 
(Jobe, 2002). During this stage, differentiated bronchiolar Clara cells start to synthesize CCSP 
(Singh et al., 1988; Zhou et al., 1996a), and the cuboidal cells differentiate into specialized 
type II epithelial cells and subsequently into type I epithelial cells that subsequently will form 
the alveolar epithelium (Jobe, 2002).  
 
The saccular stage 
During the saccular stage, the segments distal to the terminal bronchioles dilate and expand, 
resulting in formation of alveolar saccules and ducts, and in reduction of interstitial tissue. 
The peripheral epithelial cells continue to differentiate, and the capillaries become more 
closely associated with the type I epithelial cells. Elastin is deposited in areas where the future 
alveolar septa will form to create alveoli from the terminal alveolar saccules (Burri, 2006; 
Jobe, 2002).  
 
The alveolar stage 
During the alveolar stage, the saccules subdivide into the smaller alveoli. The formed alveolar 
walls (secondary septa) contain a double capillary and connective tissue. During 
alveolarization, a single capillary layer is formed to enable efficient gas exchange after birth 
(Burri, 2006). 
  
In the human lung, alveoli begin to form during the weeks preceding birth but the large 
majority of alveoli are formed postnatally (Burri, 2006). Alveolarization continues into early 
childhood (1-2 years). At birth, 50-150 million alveoli exist in the human lung, whereas the 
adult lung contains 300 million alveoli (Burri, 2006; Jobe, 2002). Since the mouse is born 
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during the saccular stage, its alveolarization takes place postnatally beginning around 




The thin layer of liquid that lines the alveolar epithelium contains surfactant, the primary 
functions of which are to lower the surface tension, thus preventing the alveoli from 
collapsing at the end of expiration, and to enhance compliance. Lung surfactant is a complex 
of phospholipids (80-90%) and proteins (~10%) synthesized and secreted primarily by 
alveolar type II cells. Disaturated phospatidylcholine accounts for ~50% of surfactant content 
and allows packing of the surface film that reduces surface tension to nearly zero. There are 
four different surfactant proteins, the hydrophobic surfactant protein (SP)-B and SP-C and the 
hydrophilic SP-A and SP-D (Jobe, 2002). The expression of these proteins is developmentally 
regulated (Mendelson, 2000).  
 
SP-B  
SP-B is required for the formation of lamellar bodies in type II cells and for the spreading of 
lipids in the surface film to enhance the stability of the film, to enhancing proper surfactant 
function (Clark et al., 1995; Jobe, 2002). SP-B knock-out mice develop severe neonatal lung 
disease and die immediately after birth (Clark et al., 1995). Similarly, hereditary SP-B 
deficiency is lethal in human neonates (Clark and Clark, 2005). Since absence of SP-B 
inhibits the processing of SP-C (Vorbroker et al., 1995), decreased production of SP-B in 
premature infants may also decrease SP-C.  
 
SP-C 
SP-C contributes to lowering of surface tension but its presence is not essential for surfactant 
function as SP-C-deficient mice are born without signs of respiratory distress (Glasser et al., 
2001; Glasser et al., 2003). In the aging mouse, however, lack of SP-C causes interstitial lung 
disease and emphysema (large alveoli) associated with inflammation (Glasser et al., 2003). 
SP-C may be involved in the recycling of surfactant since SP-C increases the reuptake of 
surfactant phospholipids into type II epithelial cells in vitro (Horowitz et al., 1996). SP-C may 
also participate in innate host defense (Augusto et al., 2003; Glasser et al., 2008). 
 
SP-A and SP-D 
Mice deficient in SP-A or SP-C appear to have normal lung function and do not develop 
symptoms of neonatal respiratory disease (Botas et al., 1998; Korfhagen et al., 1996). 
However, lack of SP-D induces an accumulation of surfactant in the lumen of alveoli, 
suggesting a role of SP-D in surfactant homeostasis (Botas et al., 1998). SP-A and SP-D have 
important roles in host defense of the lung. They bind microorganisms and facilitate the 
uptake of infectious pathogens by alveolar macrophages (Jobe, 2002). Mice lacking either SP-
A or SP-D are more susceptible to bacterial and viral infections than wild-type mice (LeVine 
et al., 1999a; 1999b; 2000; 2004). 
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Premature birth and RDS 
The incidence of preterm delivery, i.e. birth at gestational age of less than 37 weeks, is 
approximately 13% in the United States (Martin et al., 2007), whereas only 5-6% of births in 
Sweden are preterm (Ringborg et al., 2006).  
 
Due to lung immaturity, preterm infants are at a risk of developing respiratory distress 
syndrome (RDS, or hyaline-membrane disease). Fanaroff et al. and Lemons et al. reported 
that 44% and 50%, respectively, of preterm infants with a birth weight of <1500 g (VLBW) 
develop RDS (Fanaroff et al., 2007; Lemons et al., 2001). According to a Swedish study, 37% 
of infants born before 32 weeks’ gestational age develop RDS (Lundqvist et al., 2009). The 
incidence of RDS increases with lower birth weight and lower gestational age (Fanaroff et al., 
2007; Lemons et al., 2001). The lungs of infants who die from RDS display diffuse atelectasis 
and very few dilated alveoli and have membranes of fibrotic material and cellular debris from 
the injured epithelium that line the airspaces (Rodriguez et al., 2002). RDS is a risk factor for 
the development of chronic lung disease of the neonate, also called bronchopulmonary 
dysplasia (BPD). 
 
Bronchopulmonary dysplasia  
Definition and incidence  
BPD is a chronic pulmonary disease that affects premature infants. For infants born before 32 
weeks gestational age, BPD is defined as the need for supplemental oxygen for at least 28 
days and the severity (mild, moderate or severe) of BPD is determined by the need for oxygen 
at 36 weeks’ postmenstrual age or at discharge (Jobe and Bancalari, 2001). Previously, BPD 
was defined either as oxygen requirement for at least 28 days or as oxygen requirement at 36 
weeks’ postmenstrual age. BPD occurs primarily in premature infants weighing less than 
1000 g at birth and born at 24-26 weeks of gestation, i.e. during the canalicular/saccular stage 
when neither the alveolar nor the distal vascular development is completed (Coalson, 2006). 
These infants have clinical signs of respiratory disease, such as tachypnea and retractions 
(Jobe and Bancalari, 2001). The most important risk factor for BPD is lung immaturity, as the 
incidence of BPD is negatively correlated to birth weight and gestational age (Fanaroff et al., 
2007; Lemons et al., 2001). The incidence of BPD, defined as requirement of supplemental 
oxygen at 36 weeks’ postmenstrual age, is ~50% in infants with birth weight 501-750 g, 
~34% in infants with birth weight 751-1000 g, ~15% in infants with birth weight 1001-1250 




BPD was first described by Northway and co-workers in 1967 as a lung injury caused by 
mechanical ventilation and oxygen support when treating preterm infants for RDS (Northway 
et al., 1967). This “old” BPD was characterized by fewer alveoli, fibrosis, severe airway 
epithelial hyperplasia, and areas of overinflation or atelectasis. Since then, improved 
mechanical ventilatory strategies, the use of antenatal glucocorticosteriods, and exogenous 
surfactant treatment have resulted in the survival of more immature and smaller preterm 
infants (Coalson, 2006). Thus, the lung injury seen in infants with BPD has changed, and the 
“new” BPD pathology is displayed as extreme lung immaturity and is characterized by large 
alveoli, impaired vascular development, and an inflammatory response. In contrast to the 
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“old” BPD, “new” BPD has less pronounced airway hyperplasia and fibroproliferation, and 
does not show areas of severe overinflation (Coalson, 2003; 2006).  
 
Long-term outcomes for BPD infants 
Infants with BPD are more likely to need prolonged hospitalization and readmission in the 
first years of life than preterm infants without BPD (Vrijlandt et al., 2007). Some infants with 
BPD continue to show function abnormalities into childhood and even early adulthood (Doyle 
et al., 2006; Wong et al., 2008; Vrijlandt et al., 2007). Due to their immaturity at birth, infants 
with BPD are at risk of poor neurodevelopmental outcome (Ehrenkranz et al., 2005; Schmidt 
et al., 2003).  
 
Inflammation 
The immune system comprises the innate immune system and the adapted immune system. 
Innate immunity provides the first line of defense that is not specific to a particular pathogen. 
However, the innate immune system has the ability to recognize a given class of molecules. 
Toll-like receptors (TLRs) for example recognizes lipopolysaccharide (LPS) of Gram-
negative bacteria, triggering an inflammatory response. Neutrophils and macrophages which 
can remove pathogens and damaged cells by phagocytosis are important cells of the innate 
immune system. The adaptive immune response, which includes T and B lymphocytes, is 
specific to a particular antigen challenge and includes self- and non-self recognition and 
immunologic memory (Goldsby et al., 2003).  
 
In the lung, the respiratory epithelium lined by mucus traps microorganisms, and ciliated 
epithelial cells remove the mucus from the lung. The resident alveolar macrophages represent, 
together with the respiratory epithelium, the first line of defense in the lung, and macrophages 
are important in the clearance of foreign material by phagocytosis (Marieb, 2001). When 
activated, alveolar macrophages secrete cytokines and chemokines that attract neutrophils and 
monocytes from the circulation (Maus et al., 2002). Cytokines are peptides and proteins that 
modulate the activity of cells under normal and pathological conditions. Many cytokines are 
either pro- or anti-inflammatory. However, the same cytokine can have both pro- and anti-
inflammatory properties. A chemokine is a cytokine that mediates chemoattraction.  
 
As previously mentioned, the collectins SP-A and SP-D can bind bacteria to enhance their 
susceptibility to phagocytosis (Jobe, 2002). In addition to leukocytes, bronchiolar epithelial 
cells and alveolar type II cells are capable of secreting chemoattractants (Standiford, et al., 
1998; van der Velden et al., 1998) to promote the infiltration of inflammatory cells to the lung 
(Fehrenbach, 2001; O'Brien et al., 1998). Neutrophils are often the first inflammatory cells to 
infiltrate the site of inflammatory response (Kaplanski et al., 2003). It has been suggested that 
they are important for the subsequent increase in lung monocytes/macrophages (Janardhan et 
al., 2006).  
 
Inflammation and BPD 
Most preterm deliveries that occur before 30 weeks of gestation are associated with antenatal 
infection, e.g. chorioamnionitis (Goldenberg et al., 2000). Yoon et al. demonstrated that 
amniotic fluid of mothers whose infants later developed BPD had elevated levels of several 
pro-inflammatory mediators, including interleukin (IL)-1β, IL-6, IL-8, and tumor necrosis 
factor α (Yoon et al., 1997). Elevated levels of IL-6 in cord plasma are associated with BPD 
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after preterm delivery (Yoon et al., 1999). Preterm infants with early tracheal colonization are 
at higher risk of developing BPD (Young et al., 2005).  
 
Ogden et al. demonstrated that neutrophils infiltrate the lungs of preterm infants with RDS 
soon after birth (Ogden et al., 1983). The neutrophil count in bronchoalveolar lavage (BAL) 
fluid declines rapidly by the end of the first week of life in infants who recover from RDS. In 
contrast, in infants who develop BPD, the levels of neutrophils are even higher than in RDS 
infants and remain elevated for several weeks (Ogden et al., 1983). Increased numbers of 
alveolar macrophages soon after birth are also associated with the development of RDS and 
BPD, and infants who develop BPD have higher numbers of macrophages than infants who 
recover from RDS (Merritt et al., 1983). In addition, the development of BPD is associated 
with increased levels of pro-inflammatory and chemotactic factors, such as IL-1β, IL-6, IL-8, 
CC chemokines and transforming growth factor (TGF)-β1 in the lungs of preterm infants 
(Baier et al., 2004; Kakkera et al., 2005; Kotecha et al., 1996a; Kotecha et al., 1996b; Lecart 
et al., 2000; Munshi et al., 1997; Tullus et al., 1996). Infants developing BPD have increased 
levels of intercellular adhesion molecule (ICAM)-1 and E-selectin, which enable circulating 
inflammatory cells to transmigrate into the tissue (Kim et al., 2004; Ramsay et al., 1998). 
During the inflammatory process, activated inflammatory cells and resident pulmonary cells 
contribute to an increased production of proteinases that may play an important role in the 
development of injury. Infants who develop BPD have an imbalance between proteases and 
antiproteases (Speer, 2006). Mechanical ventilation and supplemental oxygen given to 
preterm infants can cause an inflammatory response and interrupt the alveolar and vascular 
development of the lung (Coalson et al., 1999; Deng et al., 2000; Jobe et al., 2002; Warner et 
al., 1998; Yoder et al., 2000), and may possibly thus accelerate the development of injury and 
BPD in the already inflamed lung.  
 
Interleukin-1β 
IL-1β is a highly inflammatory cytokine that affects nearly every cell type and is an important 
part of the inflammatory response. IL-1β is, together with IL-1α and IL-1 receptor antagonist 
(IL-1Ra), a member of the IL-1 gene family. IL-1α and IL-1β are structurally related, and 
both are synthesized as precursors and act through the same cellular receptors (Dinarello, 
1997; Krakauer and Oppenheim, 1998).  
 
Synthesis of IL-1β 
IL-1β is produced by monocytes, macrophages, and to a lesser extent by neutrophils, 
epithelial cells, endothelial cells, and fibroblasts. It is synthesized within the cell as a 
precursor that at first remains within the cytoplasm, although a small amount of pro-IL-1β can 
be secreted. The intracellular 31 kDa pro-IL-1β is processed into the mature 17 kDa form 
primarily by the IL-1 converting enzyme (ICE or caspase-1) (Krakauer and Oppenheim, 
1998). Precursor IL-1β can also be cleaved by elastase, chymotropsin (a mast cell chymase), 
granzyme A, and matrix metalloproteinases (MMPs), e.g. MMP-9 (Dinarello, 2002; 
Dinarello, 1997).  
 
IL-1β receptors and IL-1β-signaling 
IL-1β can bind two kind of receptors, IL-1 receptor type I (IL-1RI) and IL-1 receptor type II 
(IL-1RII). IL-1RI is expressed on e.g. endothelial cells, epithelial cells, fibroblasts, and T 
lymphocytes. Binding of IL-1β to IL-1RI results in signal transduction. In contrast, binding of 
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IL-1β to IL-1RII does not give rise to an intracellular signal. IL-1β can also bind a soluble 
form of IL-1RII. This bond is nearly irreversible and prevents IL-1β actions. Another IL-1β-
antagonist is IL-1Ra that competes with IL-1β to bind to IL-1RI, thereby preventing IL-1β 
from inducing a biological response (Dinarello, 1997; Krakauer and Oppenheim, 1998). 
However, a significant inhibition of IL-1β’s biological effects is only achieved when a large 
proportion (70-80%) of the binding of IL-1β is blocked (Dayer, 2002). 
 
Effects of IL-1β 
IL-1β is a proinflammatory cytokine that is involved in the initiation and persistence of 
inflammatory response. This cytokine affects a large variety of cells and contributes to many 
responses in the human body. For example, the production of several pro-inflammatory 
cytokines and chemokines, e.g. IL-1β itself, IL-6, IL-8, tumor necrosis factor α, and 
granulocyte-macrophage colony-stimulating factor (GM-CSF) and of complement compotent 
5a (C5a) is induced by IL-1β in endothelial cells, monocytes/macrophages, and fibroblasts, 
thus increasing the attraction and activity of neutrophils, monocytes, and macrophages 
(Krakauer and Oppenheim, 1998). By inducing the expression of the cell adhesion molecules 
ICAM-1, vascular cell adhesion molecule (VCAM)-1, and E-selectin on vascular endothelial 
cells, IL-1β participates in the recruitment of leukocytes to the tissue (Dinarello, 2002; 
Krakauer and Oppenheim, 1998).  
 
IL-1β-expressing mouse as a model of BPD 
Elevated levels of IL-1β in the amniotic fluid and in the lungs of preterm infants are 
associated with the development of BPD (Kakkera et al., 2005; Kotecha et al., 1996; Yoon et 
al., 1997). Bry et al. recently demonstrated that perinatal expression of human IL-1β (hIL-1β) 
in the lung epithelium causes a pulmonary disease resembling BPD in infant mice (Bry et al., 
2007). These transgenic mice express the hIL-1β transgene from approximately embryonal 
day (E) 14 in the proximal lung epithelium, and to some extent in the distal lung epithelium 
(Perl et al., 2002). Postnatally, IL-1β-expressing mice display pulmonary inflammation with 
neutrophils and macrophages, large alveoli, thick alveolar walls, and abnormal capillary 
structure in the alveolar walls (Bry et al., 2007). In addition, mice expressing IL-1β have poor 
postnatal growth and high mortality. Since the mice were not subjected to other potential 
causes of injury, such as mechanical ventilation, oxygen therapy, or preterm delivery, the 
study demonstrated that IL-1β-induced inflammation by itself can promote the development 
of a BPD-like illness. This model provides an opportunity to identify mechanisms of 
inflammatory lung injury in the neonate.  
 
The αvβ6 integrin 
Integrins are heterodimeric transmembrane glycoproteins that are involved in cellular growth, 
migration, differentiation, and survival by mediating interactions between cells and between 
cells and the extracellular matrix (ECM) (Hynes, 2002; Sheppard, 2003). Integrins are 
expressed in many different cell types and organs. One integrin is often capable of binding 
different ligands, and one specific ligand can often bind to different integrin receptors. 
Integrin ligation can affect the expression of genes encoding MMPs, cytokines, inhibitors of 
cell cycle progression, and factors involved in apoptosis (Sheppard, 1998). Each integrin is 
composed of one α-subunit and one β-subunit. To date, 18 human α-subunits and 8 β-subunits 
have been identified. These subunits form 24 different heterodimers (Sheppard, 2003). Some 
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integrins are involved in inflammation, such as β2- and α4-integrins, which mediate leukocyte 
adhesion by binding adhesion molecules on endothelial cells, as well as the αvβ6 integrin.  
 
Expression and function of the αvβ6 integrin 
The β6 integrin subunit was first identified in primary cultures of airway epithelial cells 
(Sheppard et al., 1990). This subunit binds exclusively the αv subunit, forming the αvβ6 
integrin (Busk et al., 1992). The expression of the αvβ6 integrin has been detected 
predominantly in epithelial cells (Breuss et al., 1993; Breuss et al., 1995). Breuss et al. 
showed that this integrin is expressed basally or at cell–cell borders in the human fetal lung 
(~18 weeks’ gestational age) in epithelial cells of the branching distal airways, while it is 
generally absent from proximal airways (Breuss et al., 1995). In the newborn monkey lung, 
αvβ6 integrin is strongly expressed in alveolar epithelial cells and in cells lining the 
respiratory bronchioles, but is rarely detected in airways. In healthy adult primates, the 
expression of the αvβ6 integrin is undetectable except in the uterus and kidney. Pulmonary 
expression of the β6 integrin subunit is markedly upregulated in response to injury and 
inflammation. Injury of the airway epithelium induces the expression of several integrin 
subunits, including the αv subunit and the β6 subunit, suggesting that the αvβ6 integrin 
participates in epithelial repair (Dosanjh et al., 2004; Pilewski et al., 1997). In skin wounds, 
the expression of the αvβ6 integrin is highly induced in keratinocytes soon after injury 
(Breuss et al., 1995; Haapasalmi et al., 1996), and its expression is important for keratinocyte 
migration in vitro (Huang et al., 1998a), suggesting a possible role of the αvβ6 integrin in 
migration of epithelial cells to traumatized areas. However, the αvβ6 integrin is not essential 
to the healing of epidermal wounds (Huang et al., 1998b). The expression of αvβ6 integrin is 
also induced in alveolar type II epithelial cells after acute lung injury (ALI) (Breuss et al., 
1995), and in the respiratory epithelium of smokers (Weinacker et al., 1995), and in adult 
patients with allergic alveolitis, chronic obstructive pulmonary disease (COPD) (Breuss et al., 
1995), or cystic fibrosis (Pilewski et al., 1997).  
 
The αvβ6 integrin mediates attachment of epithelial cells to the ECM by binding fibronectin 
(Busk et al., 1992; Weinacker et al., 1994), vitronectin (Huang et al., 1998a) or tenascin-C 
(Prieto et al., 1993; Yokosaki et al., 1996) and mediates the spreading and proliferation of 
epithelial cells (Agrez et al., 1994). The αvβ6 integrin is an in vivo activator of the profibrotic 
cytokine TGF-β1 (Munger et al., 1999), which is thought to be involved in BPD (Kotecha et 
al., 1996a; Lecart et al., 2000; Vicencio et al., 2004), inflammation (Sheppard, 2006), and 
adult pulmonary diseases (Munger et al., 1999; Pittet et al., 2001). 
 
Knock-out mice lacking the β6 integrin subunit 
To identify in vivo functions of the αvβ6 integrin, the study of knock-out mice lacking the β6 
integrin subunit (Huang et al., 1996) has been a useful approach, as the β6 subunit pairs 
exclusively with the αv subunit. The αvβ6 integrin is not essential to normal embryonic 
development, since β6 knock-out mice homozygous for the null mutation are born in expected 
Mendelian ratios (Huang et al., 1996). Mice lacking the β6 integrin reproduce normally and 
appear healthy until adulthood, except for juvenile baldness on forehead, neck and thighs. 
However, adult β6-deficient mice develop spontaneous lung inflammation (Huang et al., 
1996; Huang et al., 1998b) and age-related MMP-12-dependent emphysema (Morris et al., 
2003). Surprisingly, β6-deficient mice are protected from bleomycin-induced fibrosis, a 
pulmonary disease often preceded by inflammation (Munger et al., 1999). Absence of the β6 
integrin subunit also protects adult mice from bleomycin-induced ALI (Pittet et al., 2001). 
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Since spontaneous lung inflammation in β6-deficient mice precedes the bleomycin-induced 
injury in these studies, it is suggested that the spontaneous inflammation may have rendered 
the lungs resistant to subsequent injury (Pittet et al., 2001). It was recently demonstrated that 
absence of the αvβ6 integrin protects adult mice from IL-1β-induced ALI by completely 
inhibiting IL-1β-mediated protein permeability across alveolar epithelial cells (Ganter et al., 
2008). The role of the αvβ6 integrin in pulmonary diseases of the fetus or newborn has not 
previously been investigated.   
 
Matrix metalloproteinase-9 
MMPs, a family of zinc-dependent proteinases, are divided into several subclasses according 
to substrate specificity and structural characteristics. The group of gelatinases includes MMP-
2 (gelatinase A) and MMP-9 (gelatinase B). Gelatinases degrade ECM proteins, contribute to 
tissue remodeling, and modulate cell migration, vascularization, and the activity of 
inflammatory factors (Atkinson and Senior, 2003; Chakrabarti and Patel, 2005).  
 
Expression of MMP-9 
MMP-9 is expressed during lung development, but it is not essential to normal lung 
development since the lungs of MMP-9-deficient mice appear normal (Betsuyaku et al., 2000; 
Chakrabarti and Patel, 2005). The adult lung normally does not contain MMP-9, but 
inflammation induces transcription of MMP-9 and attracts neutrophils that secrete pro-MMP-
9. Resident cells such as bronchiolar epithelial cells, Clara cells, alveolar type II cells, 
fibroblasts, and endothelial cells produce MMP-9 when stimulated. MMP-9 is also produced 
by leukocytes, most notably neutrophils, which produce MMP-9 and secrete MMP-9 from 
granules in an inducible manner (Atkinson and Senior, 2003; Chakrabarti and Patel, 2005).  
  
MMP-9 is released as a proenzyme, requiring activation by cleavage of the prodomain by e.g. 
stromelysin-1 (MMP-3) or MMP-2. The activity of MMP-9 is controlled by the expression of 
tissue inhibitor of metalloproteinase (TIMP)-1, which can bind and inactivate both active 
MMP-9 and pro-MMP-9 (Atkinson and Senior, 2003; Chakrabarti and Patel, 2005).  
 
MMP-9 function 
MMP-9 degrades gelatin, collagen, elastin, vitronectin and fibonectin, as well as cytokines 
and growth factors (Atkinson and Senior, 2003; Chakrabarti and Patel, 2005). It also activates 
pro-IL-1β (Schönbeck et al., 1998) and latent TGF-β (Yu and Stamenkovic, 2000). MMP-9 
changes the structure of the neutrophil chemoattractant IL-8, thus increasing its chemotactic 
activity (Van den Steen et al., 2000), and by degrading α1-antitrypsin MMP-9 protects the 
activity of neutrophil elastase (Liu et al., 2000). On the other hand, MMP-9 decreases the 
attraction of inflammatory cells by inactivating keratinocyte-derived chemokine (KC) (Van 
den Steen et al., 2000).  
 
MMP-9 in lung injury 
MMP-9-deficient adult mice are protected from IL-13-induced emphysema and are partially 
protected from edema in bleomycin-induced ALI despite high numbers of inflammatory cells 
in BAL fluid (Lanone et al., 2002; Warner et al., 2001), suggesting that MMP-9 is involved in 
adult pulmonary disease.  
 
 16  
Increased levels of MMP-9 and an imbalance between MMP-9 and TIMP-1 in preterm infants 
have been associated with the development of BPD (Ekekezie et al., 2004; Fukunaga et al., 
2009; Schulz et al., 2004). In addition, elevated expression of MMP-9 and higher ratios of 
MMP-9 to TIMP-1 have been observed in a baboon model of BPD (Tambunting et al., 2005). 
Decreased expression of MMP-9 has been associated with arrested alveolarization in 
hyperoxia-exposed newborn rat lungs (Hosford et al., 2004), whereas increased production of 
MMP-9 were induced by hyperoxia in another study (Cederqvist et al., 2006). Recently, 
MMP-9-deficient newborn mice have been shown to be protected from hyperoxia-induced 
lung injury (Chetty et al., 2008). Blocking the activity of MMP (Ekekezie et al., 2004), or 
more specifically, of MMP-9 (Chetty et al., 2008) has been suggested as a potential 
therapeutic approach to prevent BPD. On the other hand, Albaiceta et al. demonstrated that 
lack of MMP-9 worsens ventilator-induced lung injury (Albaiceta et al., 2008). Thus, the role 
of MMP-9 in BPD is poorly defined.  
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AIMS OF THE THESIS 
 
The general purpose of this thesis was to identify mechanisms involved in inflammation-
induced lung injury using a transgenic mouse model of neonatal lung disease. In these mice, 
hIL-1β is expressed in the lung epithelium in an inducible manner.  
 
The specific aims were: 
 
• To investigate the role of the β6 integrin subunit in IL-1β-induced lung injury in 
newborn mice.  
 
• To investigate the role of MMP-9 in IL-1β-induced lung injury in newborn mice.  
 
• To study how expression of IL-1β in the distal lung epithelium affects pulmonary 
development and the expression of surfactant proteins in the lungs of fetal mice. 
 
 18  
MATERIALS AND METHODS 
 
The tetracycline-dependent transgenic mouse model (Papers I-III) 
The tetracycline-inducible system (Gossen and Bujard, 1992; Gossen et al., 1995; Kistner et 
al., 1996) consists of two transgenic mouse lines: an activator line and an operator line. The 
activator line expresses the reverse tetracycline transactivator (rtTA) transgene that is driven 
by either the rat CCSP (rCCSP) promoter or the human SP-C (hSP-C) promoter. Both of these 
promoters express rtTA in the lung epithelium. The rCCSP promoter directs the expression of 
rtTA primarily to bronchiolar cells but also to some alveolar cells, whereas the hSP-C 
promoter results in the expression of rtTA primarily by type II epithelial cells (Akeson et al., 
2003; Perl et al., 2002; Perl et al., 2009). In the present studies, the operator line contains the 
(tetO)7 tetracycline operator, the inactive cytomegalovirus (CMV) minimal promoter, and the 
target transgene, mature hIL-1β (Lappalainen et al., 2005). Mice bearing the rCCSP-rtTA or 
hSP-C-rtTA transgene continuously express rtTA from ~E14 or ~E11, respectively (Bry et 
al., 2007; Perl et al., 2002). In the presence of doxycycline, rtTA binds the (tetO)7 element, 
thus activating the CMV promoter that induces the expression of the target transgene. To be 
able to express the target transgene, the mouse needs to have both transgenic constructs (these 
mice are referred to as bitransgenic mice) and receive doxycycline. Single-transgenic mice 
bearing only one of the transgenic constructs (the activator line or the operator line) are not 
able to express the target transgene. 
 
To produce bitransgenic rCCSP-rtTA/(tetO)7-CMV-hIL-1β offspring and single-transgenic 
rCCSP-rtTA offspring, mice bearing the rCCSP-rtTA construct were mated with mice bearing 
the (tetO)7-CMV-hIL-1β construct (Fig. 1) (Papers I, II). To produce bitransgenic hSP-C-
rtTA/(tetO)7-CMV-hIL-1β offspring and single-transgenic hSP-C-rtTA offspring, mice 
bearing the hSP-C-rtTA construct were mated with mice bearing the (tetO)7-CMV-hIL-1β 
construct (Paper III). Doxycycline administered to pregnant and nursing dams passes 
transplacentally to the fetuses and via milk to the pups, resulting in expression of IL-1β in 
bitransgenic offspring but not in single-transgenic offspring (Fig. 1). The expression of IL-1β 
in bitransgenic mice is induced by doxycycline from ~E11 in the SP-C model (Paper III) and 
from ~E14 in the CCSP model (Papers I, II). 
 
Since the expression of rtTA, controlled by the rCCSP promoter or the hSP-C promoter, can 
affect the structure and function of the lung (Sisson et al., 2006), it is necessary to use single-
transgenic rCCSP-rtTA and hSP-C-rtTA littermates as controls to specifically study the 
effects of IL-1β in rCCSP-rtTA/(tetO)7-CMV-hIL-1β and hSP-C-rtTA/(tetO)7-CMV-hIL-1β 
mice, respectively.  
 
To investigate the role of the β6 integrin subunit in IL-1β-induced lung injury (Paper I), mice 
lacking both alleles of the β6 integrin subunit (β6-/-) were mated with transgenic rCCSP-rtTA 
mice and transgenic (tetO)7-CMV-hIL-1β mice to produce rCCSP-rtTA β6-/- mice and (tetO)7-
CMV-hIL-1β β6-/- mice. The single-transgenic offspring were then mated to produce 
bitransgenic rCCSP-rtTA/(tetO)7-CMV-hIL-1β β6-/- offspring and single-transgenic rCCSP-
rtTA β6-/- offspring. Abbreviations used for transgenic mice are shown in Table 2.  
 
 
 19  
+
rCCSP-rtTA














Figure 1. To produce bitransgenic (rCCSP-rtTA/(tetO)7-CMV-hIL-1β) offspring and littermate 
single-transgenic (rCCSP-rtTA) offspring, mice bearing the rCCSP-rtTA transgenic construct 
were mated with mice bearing the (tetO)7-CMV-hIL-1β transgenic construct. In the presence of 
doxycycline, rtTA binds the (tetO)7 element in the bitransgenic offspring and the expression of 
IL-1β is induced. In the single-transgenic offspring, rtTA is present, but since the mouse does not 
have the (tetO)7-CMV-hIL-1β transgenic construct, IL-1β cannot be induced. In Paper III, the 
rtTA expression was similarly controlled by the hSP-C promoter.  
 
Table 2. Abbreviations used for transgenic mice   
Abbreviation Transgene Paper 
control/β6+/+  rCCSP-rtTA mouse with wild-type integrin β6 loci I 
control/β6-/- rCCSP-rtTA mouse with null integrin β6 loci I 
 IL-1β/β6+/+  rCCSP-rtTA/(tetO)7-CMV-hIL-1β mouse with wild-type integrin β6 loci I 
 IL-1β/β6-/-  rCCSP-rtTA/(tetO)7-CMV-hIL-1β mouse with null integrin β6 loci I 
control/MMP-9+/+  rCCSP-rtTA mouse with wild-type MMP-9 loci II 
control/MMP-9-/- rCCSP-rtTA mouse with null MMP-9 loci II 
 IL-1β/MMP-9+/+  rCCSP-rtTA/(tetO)7-CMV-hIL-1β mouse with wild-type MMP-9 loci II 
 IL-1β/MMP-9-/-  rCCSP-rtTA/(tetO)7-CMV-hIL-1β mouse with null MMP-9 loci II 
 
To investigate the role of MMP-9 in IL-1β-induced lung injury (Paper II), mice lacking both 
alleles of MMP-9 (MMP-9-/-) were mated with transgenic rCCSP-rtTA mice and transgenic 
(tetO)7-CMV-hIL-1β mice to produce rCCSP-rtTA MMP-9-/- mice and (tetO)7-CMV-hIL-1β 
MMP-9-/- mice. The single-transgenic offspring were then mated to produce bitransgenic 
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rCCSP-rtTA/(tetO)7-CMV-hIL-1β MMP-9-/- offspring and single-transgenic rCCSP-rtTA 
MMP-9-/- offspring. Abbreviations used for transgenic mice are shown in Table 2.  
 
All mice were in FVB/N background.  
 
Genotype determination (Papers I-III) 
DNA was extracted from mouse tails for genotyping by polymerase chain reation (PCR) 
analysis with subsequent separation on agarose gel containing ethidium bromide and detection 
with UV light. The specific primers (5' to 3′) for transgenic constructs are given in Table 3. 
  
Table 3. Primers used for genotyping by PCR   
Construct/Gene   Primer sequence (5' - 3') Paper 
        
rCCSP-rtTA  F in rCCSP: ACT GCC CAT TGC CCA AAC AC I, II 
  R in rtTA: AAA ATC TTG CCA GCT TTC CCC  
hSP-C-rtTA  F in hSP-C: GAC ACA TAT AAG ACC CTG GTC A III 
  R in rtTA: AAA ATC TTG CCA GCT TTC CCC  
(tetO)7-CMV-hIL-1β   F in CMV: CCA TCC ACG CTG TTT TGA CC I, II, III 
    R in hIL-1β: ACG GGC ATG TTT TCT GCT TG  
β6 integrin   F: TAG CTT CCA GCC AAG GTG GG I 
  R: TCT GAG GGA CTG GTA TGT GTG TCC  
MMP-9   F: GTG GGA CCA TCA TAA CAT CAC A II 
    R: CTC GCG GCA AGT CTT CAG AGT A   
 
Administration of doxycycline (Papers I-III) 
Doxycycline (0.5 mg/ml, Sigma, St. Louis, MO) was administered in drinking water to 
pregnant and nursing dams to induce hIL-1β transgene expression in the lungs of bitransgenic 
fetuses and pups. The administration of doxycycline extended from the beginning of 
pregnancy until sacrifice of fetuses on E15 (Paper III) or E18.5 (Paper III) or of pups on PN0 
(Paper I), PN4 (Paper II) or PN7 (Papers I-III). Since the doxycycline solution is light-
sensitive and its activity decreases at room temperature after 72 h (Perl et al., 2002), cage 
bottles with doxycycline were covered with aluminum foil and the solution was changed three 
times per week.  
 
Animal care (Papers I-III) 
The mice were housed in pathogen-free conditions at Experimental Biomedicine, University 
of Gothenburg and all animal experiments were approved by the Ethical Committee of 
Gothenburg. All animals were given access to water and chow ad libitum. For sample 
collection of fetal lungs on E14, E15 or E18.5, fetuses were removed by hysterectomy after 
anesthesia by intraperitoneal injection of a mixture of ketamine, xylazine, and acepromazine 
to the pregnant dam. For lung sample collection from infant mice on PN0, PN4 or PN7, pups 
were anesthetized by intraperitoneal injection of a mixture of ketamine, xylazine, and 
acepromazine, the abdomen was opened, and the animal was exsanguinated by transection of 
the abdominal aorta. The day of plug was counted as E0 and the day of birth as PN0. After 
birth, the pups were counted each day to assess survival data until sample collection. Fetuses 
and pups were weighed at the time of sacrifice.  
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Protein measurements with ELISA (Papers I-III) 
Lung tissue was homogenized in sterile-filtered phosphate buffered saline (PBS) containing 
protease inhibitor (Complete; Roche Diagnostics, Basel, Switzerland) and centrifuged at 
10,000 g at 4ºC for 10 min to remove cell debris prior to analysis of the collected supernatant. 
Total protein concentration was measured using the bicinchoninic acid method (Sigma). To 
measure hIL-1β in whole lung homogenates (Papers I-III), enzyme-linked immunosorbent 
assay (ELISA) DuoSet specific for human IL-1β, with no cross-reactivity with murine IL-1β, 
was used (R&D Systems, Abingdon, UK).  
 
DuoSet ELISA development kits (R&D Systems) were used to quantify mouse KC (Papers I, 
II), macrophage-inflammatory protein (MIP)-2 (Paper I), monocyte chemoattractant protein 
(MCP)-1 (Papers I, II), osteopontin (Paper I), and vascular endothelial growth factor (VEGF; 
Paper II). Assay standard concentration ranges were 3.9-250 pg/ml (IL-1β, MCP-1), 7.8-1000 
pg/ml (VEGF) and 15.6-1000 pg/ml (KC, MIP-2, osteopontin). 
 
Active TGF-β1 was measured according to manufacturer’s instructions (R&D Systems) 
(Paper I). To enable determination of total TGF-β1 levels, acidification of the samples was 
performed according to manufacturer’s instructions (R&D Systems) to transform latent TGF-
β1 into the immunoreactive form. After acidification the samples were neutralized prior to 
ELISA. Assay standard concentration range was 7.8-1000 pg/ml.  
 
Western blot to detect degraded hIL-1β (Paper II) 
Since MMPs can degrade mature IL-1β (Ito et al., 1996; Schönbeck et al., 1998), the presence 
of degraded hIL-1β (17 kDa) in whole lung homogenates was studied in MMP-9+/+ and 
MMP-9-/- mice by western blotting. Lung tissue was homogenized in sterile-filtered PBS 
containing protease inhibitor (Complete; Roche). The detergent Nonidet P-40 (Roche 
Diagnostics) was added to the homogenized tissue to liberate membrane-bound proteins 
before centrifugation at 10,000 g at 4ºC for 10 min. The supernatant was collected for 
analysis. Equal amounts of total protein were separated by molecular mass by sodium dodecyl 
sulfate polyacrylamide gel electrophoresis (SDS-PAGE) on a 4-12% gradient gel (Invitrogen, 
Carlsbad, CA). A protein ladder (10-200 kDa; Cell Signaling Technology, Danvers, MA) was 
also loaded on the gel. After electrophoresis, proteins were electrotransferred onto a 
polyvinylidene difluoride (PVDF) membrane (Amersham Bioscience, Little Chalfont, UK). 
The membrane was blocked with 5% milk powder (Cell Signaling Technology) before 
overnight (4ºC) incubation with the primary anti-human IL-1β rabbit polyclonal antibody 
(Abcam, Cambridge, UK). Thereafter, the membrane was incubated with anti-rabbit 
horseradish peroxidase (HRP)-linked secondary antibody (Cell Signaling Technology) and 
anti-biotin HRP-linked antibody (Cell Signaling Technology). Enhanced chemiluminescence 
was used according to manufacturer’s instructions (Lumigen Inc., Southfield, MI) to visualize 
the proteins, which were detected in a luminescence image analyzer (LAS-100, Fujifilm; 
Stamford, CT) and quantified with Image Gauge v4.2 software (Fujifilm). After detection of 
hIL-1β the same membrane was used to detect β-actin as a loading control, and the 
densiometric values for IL-1β were normalized to β-actin.  
 
Lung histology (Papers I-III) 
For fixation of postnatal lung samples, the lung was inflation-fixed by instillation of 4% PBS-
buffered paraformaldehyde at a pressure of 25 cm H2O. The fixative was perfused into the 
lung via a blunt cannula inserted in the trachea. After fixation the lungs were taken out of the 
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thoracic cavity and placed in 4% PBS-buffered paraformaldehyde. For sample collection of 
embryonal lungs, the lungs were transferred to 4% PBS-buffered paraformaldehyde without 
preceding inflation fixation. After overnight fixation at 4°C, the tissue was dehydrated 
through a graded series of ethanol and xylene prior to paraffin embedding. Five-micrometer 
thick tissue sections were used for staining with hematoxylin and eosin, alcian blue/periodic 
acid Schiff (AB/PAS), and for immunohistochemistry.  
 
Determination of the alveolar chord length (Papers I-III) 
Chord length analysis of the distal lung was used as a measure of the size of the airspaces. A 
minimum of ten representative non-overlapping fields (20x lens) per lung section stained with 
hematoxylin and eosin were acquired in 8-bit grayscale image using a Nikon Eclipse E800 
microscope and a Nikon DXM1200 digital camera. Final magnification was 1.89 pixels per 
micrometer. Chord length analysis was performed using the public domain program NIH 
Image (available from the U.S. National Institutes of Health at http://rsb.info.nih.gov/nih-
image) to measure the intra-alveolar distance in binarized images of lung tissue at PN4 or 
PN7. Areas of bronchiolar airways and blood vessels were not included in the analysis. The 
mean chord length in a single image was calculated using the NIH Image program.  
 
Determination of alveolar wall thickness (Papers I, II) 
The same images that were used for measuring the mean chord length were used for 
measuring the thickness of distal airspace walls at PN4 or PN7 with ImageJ (available from 
NIH at http://rsb.info.nih.gov/nih-image) (Papers I, II). A minimum of ten non-overlapping 
fields (images) were analyzed by drawing at least 30 straight lines at 90º angles across the 
narrowest segment of the wall. The mean length of lines crossing the walls was determined 
using ImageJ.  
 
Quantification of airspaces in the fetal lung (Paper III) 
Airspace area fraction at E18.5 was measured in lung sections stained with hematoxilin and 
eosin. Using the public domain program ImageJ, the percentage of airspace area of total lung 
area was determined using binarized lung images. Five representative non-overlapping fields 
from the lungs of five mice per group were analyzed. The same images were also used to 
count the number of airspaces.  
 
Detection of mucus-producing cells (Papers I, II) 
To visualize mucus production in airway cells, AB/PAS staining was performed as previously 
described (Cook, 1996) (Papers I, II). Briefly, dehydrated paraffin sections were stained in 
alcian blue solution (pH 2.5) to detect acid mucins followed by detection of neutral mucins 
with periodic acid and Schiff’s reagent (Merck, Darmstadt, Germany). Nuclei were stained 
with Mayer’s hematoxilin. The number of AB/PAS-positive and AB/PAS-negative cells 
within the airways was counted and the percentage of positive cells per airway was calculated. 
At least ten airways were analyzed per section. The distribution of airways having various 
percentages of AB/PAS-positive cells (<20%, 20-80%, or >80%) was compared between 
different genotypes (Paper I).  
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Immunohistochemistry (Papers I-III) 
For immunohistochemistry, lung tissue sections were deparaffinized and rehydrated. Citrate 
buffer (pH 6) (CCSP, Mac3, MMP-9, neutrophil-7/4, pro-SP-C, SP-B) or 0.1% trypsin 
(platelet endothelial cell adhesion molecule (PECAM)-1) was used as antigen retrieval and 
methanol with hydrogen peroxide was used to block endogenous peroxidase. Sections were 
incubated with appropriate serum to block non-specific binding before the use of primary 
antibodies (Table 4) and biotinylated secondary antibodies (Vector Laboratories, Burlingame, 
CA). After incubation with a secondary antibody, sections were incubated with avidin-biotin 
peroxidase (Vectastain Elite ABC; Vector Laboratories) and immunoreactivity was visualized 
using peroxidase substrate; 3.3-diaminobenzidine (DAB; Vector Laboratories; MMP-9, pro-
SP-C, SP-B) or NovaRED (Vector Laboraties; CCSP, Mac3, neutrophil-7/4, PECAM-1). 
Sections were lightly counterstained with nuclear fast red after incubation with DAB or with 
Mayer’s hematoxylin (nuclear counterstaining) after incubation with NovaRED. 
Immunostained cells were counted in the distal airspaces and/or distal septal walls in at least 
ten non-overlapping high power fields (HPFs, 400x or 1000x magnification) from at least four 
animals per group. Due to the small lung size at E14 (Paper II), neutrophils and macrophages 
were counted in five HPFs. In Papers I and III, the number of positive cells per square 
millimeter septa or square millimeter airspace was calculated.  
 
Table 4. Antibodies used for immunohistochemistry    
Primary antibody Source Dilution Company Paper 
CCSP Rabbit polyclonal 1:500 Seven Hills Bioreagents III 
   Cincinnati, OH  
          
Ki-67 Rabbit polyclonal 1:500 Novocastra Laboratories Ltd. I, III 
   Newcastle-upon-Tyne, UK  
          
Mac3, clone M3/84 Rat monoclonal 1:50 BD PharMingen, San Diego, CA I, II, III
          
MMP-9 Goat polyclonal 1:100 R&D Systems, Abingdon, UK II 
          
Neutrophils, clone 7/4 Rat monoclonal 1:50 Serotec, Oxford, UK I, II, III
          
PECAM-1 (CD31) Rat monoclonal  BD PharMingen, San Diego, CA II 
          
Pro-SP-C Rabbit polyclonal 1:1000 Chemicon International III 
   Temecula, CA  
          
SP-B Rabbit polyclonal 1:500 Chemicon International III 
      Temecula, CA   
 
Detection of proliferating cells with Ki-67 immunostaining (Papers I, III) 
Five-micrometer thick lung tissue sections were deparaffinized, rehydrated and treated with 
citrate buffer (pH 6) and methanol with hydrogen peroxide. After incubation with goat serum, 
polyclonal rabbit anti-human Ki-67 antibody that cross-reacts with murine Ki-67 (Table 4) 
was used to detect proliferating cells (Scholzen and Gerdes, 2000), followed by biotinylated 
goat anti-rabbit secondary antibody (Vector Laboratories). Avidin-biotin peroxidase 
(Vectastain Elite ABC; Vector Laboratories) and DAB (Vector Laboratories) were used 
according to manufacturer’s instructions, and sections were counterstained with nuclear fast 
red. The number of Ki-67-positive cells was counted in the distal lung in at least ten non-
overlapping HPFs (400x magnification). 
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Detection of apoptotic cells with TUNEL (Papers I-III) 
During apoptosis, 3’ strand breaks occur within the DNA. These breaks can be detected by 
terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick-end-labeling (TUNEL). 
The template-independent TdT (Roche Diagnostics) catalyzes the addition of nucleotides to 
the 3’-end of single- and double-stranded DNA. The TUNEL method was performed on 5 μm 
thick paraffin-embedded lung tissue sections as previously described (Lukkarinen et al., 
2003). Briefly, TdT-incorporated digoxigenin-dideoxyuridine-triphospate (dig-ddUTP, 
Roche) into fragmented DNA was detected with an anti-digoxigenin alkaline phosphates-
labeled antibody (Roche Diagnostics). Addition of 5-Bromo-4-chromo-3-indolyl 
phosphate/nitro blue tetrazolium (BCIP/NBT; Vector Laboratories) resulted in a substrate 
color reaction, regarded as representing DNA fragmentation. TUNEL-positive cells were 
counted in the distal lung in at least 10 non-overlapping fields.  
 
Quantitative real-time RT-PCR (Papers I-III) 
Lung tissue was transferred to RNA-stabilizing solution (RNA-later; Ambion, Austin, TX) 
immediately after opening of the thorax. Total RNA was isolated using TRIzol reagent 
according to manufacturer’s instructions (Invitrogen) and treated with RNase-free DNase 
(DNA-free; Ambion). After measuring the RNA concentration (NanoDrop Technologies Inc., 
Wilmington, DE), one microgram of total RNA was reverse transcribed (Omniscript; Qiagen, 
Hilden, Germany) into cDNA. Twenty nanograms of cDNA were analyzed by quantitative 
real-time (RT) PCR on Mx3000P RT-PCR instrument (Stratagene, La Jolla, CA) using 
Brilliant SYBR Green Q-PCR Master mix (Stratagene) and primers specific for each gene 
(Table 5). The results were normalized to β-actin mRNA levels.  
 
Gelatin zymography (Paper II) 
Zymography was used to evaluate the gelatinolytic activity of MMP-2 and MMP-9. Lung 
tissue was homogenized in sterile PBS and centrifuged at 10,000 g at 4ºC for 10 min to 
remove cell debris. The supernatant was used for analysis. Total protein concentration was 
measured using bicinchoninic acid method (Sigma). Equal amounts of total protein, together 
with Novex Tris-Glycine sodium dodecylsulphate (SDS) sample buffer (Invitrogen), were 
loaded on a 10% Novex Zymogram gel containing gelatin (Invitrogen) and processed 
according to manufacturer’s instructions. Proteins were separated according to molecular 
mass on the Zymogram gel by electrophoresis. To distinguish between the different MMPs, 
the position of the samples after separation was compared to a ladder containing proteins of 
known molecular masses, also loaded on the Zymogram gel. The MMPs, including the pro-
forms, were activated and allowed to digest the gelatin of the gel. Thereafter, the gels were 
stained with Simply Blue (Invitrogen) in order to obtain a dark-blue background to visualize 
the enzymatic activity as clear bands, which were quantified using NIH Image Software.  
 
Statistical analysis (Papers I-III) 
Data are presented as mean ± SEM. Groups of normally distributed data were compared with 
Student’s t test followed by Bonferroni correction. Two-way ANOVA was used for analysis 
of time-dependent MMP-9 mRNA expression (Paper II). Postnatal survival data were 
analyzed using Kaplan-Meier survival analysis and logrank test (Papers I-III). P values < 0.05 
were considered statistically significant. Statistical analysis was assessed using GraphPad 
Prism™ software (GraphPad Software Inc., San Diego, CA). 
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Table 5. Primers used for quantitative RT-PCR   
Gene  Primer sequence (5' - 3') Paper 
β-actin  F: TCC GTA AAG ACC TCT ATG CCA ACA I, II, III 
  R: CTC AGG AGG AGC AAT GAT CTT GAT  
CCSP  F: GAT ACC CTC CCA CAA GAG ACC AGG ATA III 
  R: GGC AGT GAC AAG GCT TTA GCA GTA GAA  
CXCR2  F: CCT CAG ACT TTT GGC TTC CTC GT I 
  R: CGC AGT GTG AAC CCG TAG CAG A  
hIL-1β  F: CCA TCC ACG CTG TTT TGA CCT C I, II, III 
  R: ACC AAG CTT TTT TGC TGT GAG TCC  
KC  F: AAA CCG AAG TCA TAG CCA CAC TCA I, II, III 
  R: CTT GGG GAC ACC TTT TAG CAT CTT  
MCP-1  F: GCT CTC TCT TCC TCC ACC ACC AT I, II 
  R: GCT CTC CAG CCT ACT CAT TGG GAT  
MCP-3  F: TCT GCC ACG CTT CTG TGC CT I, III 
  R: GCT CTT GAG ATT CCT CTT GGG GAT  
MIP-2  F: CCC CCT GGT TCA GAA AAT CAT C I 
  R: AAC TCT CAG ACA GCG AGG CAC ATC  
MMP-9  F: TTC GCA GAC CAA GAG GGT TTT C II 
  R: AAG ATG TCG TGT GAG TTC CAG GGC  
Osteopontin  F: CGG TGA AAG TGA CTG ATT CTG GCA I 
  R: CGC AAG GAG ATT CTG CTT CTG AGA  
Pendrin  F: GCA GAA CCA GGT CAA ATC CAG A III 
  R: TCT CAG GAA GCA AGT CTA CGC A  
S100A8  F: GAG CAA CCT CAT TGA TGT CTA I, III 
  R: TGC ATT GTC ACT ATT GAT GTC CA  
S100A9  F: GCC AAC AAA GCA CCT TCT CAG AT I, III 
  R: GCC ATC AGC ATC ATA CAC TCC TCA A  
SAA3  F: TGC TCG GGG GAA CTA TGA TGC T I, III 
  R: CCA CTC GTT GGC AAA CTG GTC A  
SP-A  F: GGA GCT TCA GAC TGC ACT CTA CGA GA III 
  R: GAC TGA CTG CCC ATT GGT GGA AA  
SP-B  F: CCA AAC CCC ACA CCT CT GAGA A III 
  R: GCT TGT CCT CTG GAG CAG GCT  
SP-C  F: GAT ACT GGT TCC GAG TCC GAT TCT III 
  R: TTC TAC CGA CCC TGT GGA TGC T  
SP-D  F: AGA GGT TGC CTT CTC CCA CTA TCA III 
  R: GCC CAC ATC TGT CAT ACT CAG GAA  
TIMP-1  F: AAG TCC CAG AAC CGC AGT GAA GA II 
  R: TCC GTC CAC AAA CAG TGA GTG TCA  
TIMP-2  F: CCC TCT GTG ACT TCA TTG TGC CCT II 
  R: TGG TGC CCA TTG ATG CTC TTC TCT  
TTF-1  F: GCT GCC GCC TTA CCA GGA III 
  R: CGT GGG TGT CAG GTG AAT CAT  
VEGF-A  F: CAC CCA CGA CAG AAG GAG AGC A III 
  R: GCA CAC AGG ACG GCT TGA AGA TGT A  
Ym1  F: GCT CAT TGT GGG ATT TCC AGC A I, III 
  R: CCT CAG TGG CTC CTT CAT TCA GAA  
Ym2  F: TTG GAG GAT GGA AGT TTG GAC CT I, III 
   R: TGA CGG TTC TGA GGA GTA GAG ACC A   








To study the role of the β6 integrin subunit in IL-1β-induced lung disease in infant mice, the 
lung development was studied in mice expressing IL-1β with wild-type or null β6 integrin 
loci.  
 
Similar production of IL-1β in IL-1β/β6+/+ and IL-1β/β6-/- mice 
Absence of the β6 integrin subunit did not change the mRNA expression or protein 
production of IL-1β in bitransgenic mice.  
 
Absence of β6 integrin subunit improved growth and survival in IL-1β-expressing mice 
IL-1β inhibited the postnatal growth in both β6+/+ and β6-/- mice, but to a lower degree in the 
absence of the β6 integrin subunit despite the lower body weight of control/β6-/- mice 
compared to control/β6+/+ mice at PN7 (Paper I; Fig. 1A). Only ~50% of the IL-1β/β6+/+ mice 
survived until PN7, whereas 98% of the IL-1β/β6-/- mice survived until PN7 (Paper I; Fig. 
1B).  
 
Absence of β6 integrin subunit ameliorated alveolar development in IL-1β-expressing mice 
Absence of the β6 integrin did not cause detectable changes in alveolar size or alveolar wall 
thickness at PN7 in control mice (Fig. 2) (Paper I; Fig. 2A-F). Perinatal production of IL-1β 
in bitransgenic mice disrupted alveolarization in β6+/+ and in β6-/- mice, as demonstrated by 
greater alveolar chord length (a measure of alveolar size) (Fig. 2), and thicker alveolar walls 
than in littermate controls. Interestingly, IL-1β/β6-/- mice had smaller alveoli and thinner 
septal walls than IL-1β/β6+/+ mice (Fig. 2), indicating better alveolar development during 
chronic inflammation in infant mice lacking the αvβ6 integrin.  
         
Figure 2. Lung histology at PN7 of control mice (Ctrl) with (A) wild-type β6 integrin subunit loci 
(β6+/+) or (B) null β6 integrin subunit loci (β6-/-) and IL-1β-expressing mice (IL-1β) with (C) wild-type 
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Absence of β6 integrin subunit alleviated the IL-1β-induced inflammation 
Expression of IL-1β caused infiltration of the lungs of β6+/+ and β6-/- mice by neutrophils and 
macrophages (Paper I; Fig. 3A-F). While the IL-1β/β6-/- mice had similar numbers of 
neutrophils within the distal septa as IL-1β/β6+/+ mice, the number of neutrophils within the 
alveolar spaces was lower in IL-1β/β6-/- mice. The distribution of neutrophils between the 
alveolar septa and lumen was different in β6+/+ and β6-/- mice: 69% of neutrophils in IL-
1β/β6+/+ mice, but only 39% of neutrophils in IL-1β/β6-/- mice, were in the alveolar spaces 
(Fig. 3). This indicates that absence of the β6 integrin subunit affected the transmigration of 
neutrophils into the alveolar spaces. In addition, absence of the β6 integrin subunit suppressed 
the IL-1β-induced increase of macrophages in the alveolar spaces and septa.  
 
The IL-1β-induced infiltration of inflammatory cells 
was associated with enhanced expression and 
production of the neutrophil chemoattractants KC and 
MIP-2, the monocyte chemoattractants MCP-1 and 
MCP-3, as well as the chemotactic proteins S100A8, 
S100A9, serum amyloid A3 (SAA3) and osteopontin 
in both β6+/+ and   β6-/- mice (Paper I; Fig. 4A-D, Fig. 
4F-4H, Fig. 5A-E). However, the IL-1β-induced 
levels of KC, MIP-2, S100A8, S100A9, SAA3 and 
osteopontin were lower in the absence of the β6 
integrin subunit. In contrast, MCP-1 and MCP-3 
levels were elevated in the lungs of IL-1β/β6-/- mice 
compared to IL-1β/β6+/+ mice. The expression of the 
CXC chemokine receptor CXCR2 was similarly 
elevated by IL-1β in β6+/+ and β6-/- mice (Paper I; Fig. 
4E). 
 
At PN7, control/β6-/- mice had an increased number 
of neutrophils in the alveolar lumen, and elevated 
expression and production of the neutrophil- and 
macrophage-chemoattractants KC, MIP-2, MCP-1, MCP-3, S100A8, S100A9, and SAA3 
compared with control/β6+/+ mice (Paper I; Fig. 3A, Fig. 4A-4D, Fig. 4F-4H, Fig. 5A-C). In 
contrast, the numbers of macrophages in control/β6-/- and control/β6+/+ mice were similar, and 
the level of osteopontin, a macrophage chemotactic protein, was lower in control/β6-/- mice 
(Paper I; Fig. 3D-E, Fig. 5D-E).  
 
Pittet et al. suggested that spontaneous inflammation observed in adult β6-/- mice conditions 
their lungs to resist subsequent injury (Pittet et al., 2001). Since control/β6-/- mice had more 
alveolar neutrophils and greater expression of several chemoattractants at PN7 than 
control/β6+/+ mice, we sought to determine if this spontaneous inflammatory response was 
present at E14, the time at which production of hIL-1β starts in the lungs of bitransgenic mice. 
Such a spontaneous inflammation might explain the resistance of β6-/- mice to IL-1β-induced 
inflammatory lung injury. At E14, the expression of none of the chemoattractants investigated 
was higher in control/β6-/- than in control/β6+/+ fetuses (Paper I; Table 1). In addition, the 
numbers of lung neutrophils and macrophages were similar in control/β6-/- and control/β6+/+ 
fetuses (Paper I; Table 1). Thus, absence of the β6 integrin subunit did not cause spontaneous 





























Figure 3. Precentage (%) of total distal 
neutrophils detected in the alveolar 
spaces at PN7 in control (Ctrl) and IL-
1β-expressing (IL-1β) mice with wild-
type (β6+/+) or null (β6-/-) β6 integrin 
loci.  
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Absence of β6 integrin subunit alleviated IL-1β-induced goblet cell hyperplasia 
In addition to morphological changes in the distal lung of IL-1β-expressing mice, the 
proximal airways were affected by IL-1β. Expression of IL-1β caused thickening and goblet 
cell hyperplasia of the airway epithelium and accumulation of large numbers of lymphocytes 
around the airways of β6+/+ mice. These pathological changes induced by IL-1β were 
suppressed in the absence of the β6 integrin subunit (Paper I; Fig. 6A-E). In addition, the IL-
1β-induced expression of the chitinase-like lectins Ym1 and Ym2 was lower in β6-/- mice than 
in β6+/+ mice (Paper I; Fig. 6F-G).  
 
IL-1β enhanced the levels of active TGF-β1 
Since the αvβ6 integrin is an in vivo activator of TGF-β1, we measured the levels of total and 
active TGF-β1 in the lungs of infant mice. IL-1β increased the levels of active TGF-β1, but 
not of total TGF-β1 levels, in β6+/+ and β6-/- mice (Paper I; Fig. 8A-B). However, the levels of 
active TGF-β1 in whole lung homogenates did not differ between IL-1β/β6+/+ and IL-1β/β6-/- 
mice.  
 
Apoptosis and proliferation 
In control/β6+/+ mice the presence of apoptotic cells in airspaces and distal septa, as detected 
by TUNEL staining, decreased from PN0 to PN7 (Paper I; Fig. 7A-C). At birth, IL-1β 
inhibited apoptosis in β6+/+ mice but not in β6-/- mice. However, control/β6-/- mice had a 
slightly lower number of apoptotic cells than control/β6+/+ mice. At PN7, IL-1β induced 
apoptosis in both β6+/+ and β6-/- mice. The numbers of apoptotic cells in the alveolar spaces 
did not differ between IL-1β/β6+/+ and IL-1β/β6-/- mice, but the alveolar septa of IL-1β/β6-/- 
mice contained fewer apoptotic cells than those of IL-1β/β6+/+ mice. 
 
The number of proliferating cells in the distal lung increased from birth to PN7 in 
control/β6+/+ mice, but the degree of proliferation did not vary significantly among any of the 
genotypes investigated at either PN0 or PN7 (Paper I; Fig. 7D).  
 
 
Paper II  
 
IL-1β induced MMP-9 expression in the newborn lung 
In control/MMP-9+/+ mice, the expression of MMP-9 increased immediately after birth and 
remained elevated to PN5, but decreased thereafter (Paper II; Fig. 1A). IL-1β enhanced the 
age-dependent increase in MMP-9 expression several-fold and remained at high levels at 
PN7–9. IL-1β also increased pro-MMP-9 and MMP-9 activity. In contrast, levels of pro-
MMP-2 and mature MMP-2 were not altered by the expression of IL-1β. As expected, MMP-
9-/- mice lacked MMP-9 activity.  
 
To study the possible involvement of MMP-9 in IL-1β-induced lung injury, lung development 
and presence of inflammation were studied in IL-1β-expressing newborn mice with null or 
wild-type MMP-9 loci.  
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Absence of MMP-9 did not affect the production of IL-1β 
The levels of hIL-1β detected by ELISA and the levels of degraded hIL-1β (17 kDa) detected 
by Western blot were similar in IL-1β/MMP-9+/+ and IL-1β/MMP-9-/- mice. 
 
IL-1β decreased postnatal growth and survival 
Expression of IL-1β decreased postnatal growth and survival to a similar extent in MMP-9+/+ 
and MMP-9-/- mice (Paper II; Fig. 4A-B).  
 
Absence of MMP-9 worsened IL-1β-induced alveolar hypoplasia 
Alveolar development appeared normal in the absence of MMP-9, judging by alveolar size 
and septal wall thickness at PN4 and PN7 in control mice (Fig. 4) (Paper II; Fig. 3A-C). 
Expression of IL-1β disrupted alveolarization in both MMP-9+/+ and MMP-9-/- pups, as 
demonstrated by larger alveoli than in littermate controls (Fig. 4). Surprisingly, the IL-1β-
induced lack of septation was worse in the MMP-9-deficient mice (Fig. 4). Even though IL-
1β/MMP-9-/- pups had abnormally thick septal walls in the beginning of the alveolar stage at 
PN4, septal thinning subsequently occurred and septal thickness reached control levels by 
PN7.  
 
            
Figure 4. Lung histology at PN7 of control mice (Ctrl) with (A) wild-type MMP-9 loci (MMP-9+/+) or 
(B) null MMP-9 loci (MMP-9-/-) and IL-1β-expressing mice (IL-1β) with (C) wild-type MMP-9 loci 
(MMP-9+/+) or (D) null MMP-9 loci (MMP-9-/-).   
 
Altered numbers of inflammatory cells in the lungs of IL-1β/MMP-9-/- mice 
IL-1β expression increased the infiltration of neutrophils and macrophages into the lungs at 
PN4 to a similar extent in MMP-9+/+ and MMP-9-/- mice (Paper II; Fig. 6B, Fig. 7B). The 
number of neutrophils had decreased by PN7 in both IL-1β-expressing groups but was still 
higher than in littermate controls. However, IL-1β/MMP-9-/- mice had fewer neutrophils at 
PN7 than IL-1β/MMP-9+/+ mice. At PN7, more macrophages had infiltrated the lungs of IL-
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accumulation of neutrophils and macrophages in MMP-9-deficient mice was not associated 
with changes in the production of the neutrophil chemoattractant KC or the monocyte 
chemokine MCP-1 (Paper II; Table 1). IL-1β/MMP-9-/- mice had a larger proportion of 
macrophages that contained phagocytozed material than IL-1β/MMP-9+/+ mice (Paper II; Fig. 
7C-D).  
 
Increased apoptosis in IL-1β/MMP-9-/- mice 
The number of apoptotic cells was similar in control/MMP-9+/+ and control/MMP-9-/- mice. 
The IL-1β-induced apoptosis was strongly increased by MMP-9 deficiency at PN4 and PN7 
(Paper II; Fig. 5A-B).  
 
Vascularization   
Despite similar levels of VEGF production at PN4 in all groups of mice, IL-1β altered the 
structure of capillaries in the alveolar septa (Paper II; Fig. 8). In control MMP-9-/- and MMP-
9+/+ mice, the vascular endothelium, identified by PECAM staining, was in close proximity to 
the alveolar spaces and formed outsproutings towards secondary crests. IL-1β expression 
caused abnormal appearance of the capillaries. In IL-1β-expressing MMP9+/+ and MMP9-/- 
mice, the capillaries had fewer branching points and outsproutings towards secondary crests 
than in littermate controls.  
 
Paper III 
To examine how expression of IL-1β, mainly in type II epithelial cells, affects pulmonary 
development and surfactant function, mice expressing the hIL-1β transgene in the distal lung 
epithelium under the control of the hSP-C promoter were studied.  
 
IL-1β resulted in 100% mortality postnatally  
Expression of IL-1β did not affect the body weight of fetuses at E15 or E18.5 (Paper III; Fig. 
1B). Mice expressing IL-1β had a mortality of 94% (32 out of 34) at PN0, and none of the IL-
1β-expressing pups survived beyond PN1 (Paper III; Fig. 1A). In the absence of doxycycline, 
all bitransgenic pups survived until sacrifice at PN7 and gained weight as expected. Nine per 
cent (3 pups of 34) of control mice died at birth or during the first day of life.  
 
IL-1β caused prenatal lung inflammation  
IL-1β induced an inflammatory response with elevated numbers of neutrophils and 
macrophages in the distal lung parenchyma and airspaces at E18.5 and increased the 
expression of several neutrophil- and monocyte-chemoattractant proteins, namely KC, MCP-
3, S100A8, S100A9, and SAA3, at E15 and E18.5 (Paper III; Fig. 3A-C).  
 
IL-1β production resulted in prenatal arrest in acinar bud formation 
The lungs of IL-1β-expressing fetuses demonstrated arrested lung morphogenesis with a 
lower number of distal airspaces and a decreased area of distal air sacs as a percentage of total 
distal lung area compared to control mice (Fig. 5) (Paper III; Fig. 2A-D). The decreased 
mRNA expression of VEGF in IL-1β-expressing fetuses suggests that vascular development 
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may have been inhibited in the present model (Paper III; Fig. 5). IL-1β did not cause 
detectable changes in apoptosis or proliferation in the lungs at E18.5 (Paper III; Fig. 7A-B).  
 
 
Figure 5. Lung histology at E18.5 of (A) a control mouse and (B) an IL-1β-expressing mouse. IL-1β 
delayed lung development in fetal mice. Scale bar = 200 μm. 
 
IL-1β changed the expression of surfactant proteins and CCSP 
The mRNA expression of the four surfactant proteins, SP-A, -B, -C and -D increased with 
gestational age (Paper III; Fig. 4A) as expected (Mendelson, 2000). The levels of SP-A did 
not differ between IL-1β-expressing mice and littermate controls, but IL-1β decreased the 
expression of SP-B and SP-C, and increased SP-D mRNA expression. The number of cells 
that produced SP-B or pro-SP-C was decreased in IL-1β-expressing fetuses, indicating that 
IL-1β suppressed type II cell differentiation (Paper III; Fig. 4B).  
 
In the proximal airways, the number of CCSP-positive cells (Clara cells) was markedly 
decreased in IL-1β-expressing mice (Paper III; Fig. 6B). In addition, the mRNA expression of 
CCSP was suppressed by IL-1β (Paper III; Fig. 6A). In contrast, IL-1β upregulated the 
expression of Ym1, Ym2 and pendrin (Paper III; Fig. 6C), proteins associated with allergic 
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DISCUSSION 
 
The αvβ6 integrin, a potential pathogenic factor in BPD 
The αvβ6 integrin has not previously been investigated in relation to pulmonary disease of the 
newborn. Paper I demonstrates that absence of the β6 integrin subunit alleviates IL-1β-
induced lung injury in a model of BPD in newborn mice.  
 
Alveolarization 
The pulmonary pathology in infants with BPD is characterized by lack of alveolar septation, 
resulting in large alveoli and thick alveolar walls (Bhatt et al., 2001; Coalson, 2003). Alveolar 
wall thinning occurring during lung development is important for normal gas exchange (Burri, 
2006). Perinatal expression of IL-1β results in disrupted alveolar septation in infant mice, and 
thinning of alveolar walls fails to occur in IL-1β-expressing lungs (Bry et al., 2007 and Papers 
I, II). Alveolar chord length was shorter and alveolar walls were thinner in IL-1β/β6-/- lungs 
than in IL-1β/β6+/+ lungs, indicating better alveolar septation in the absence of the β6 integrin 
subunit in this model of BPD.  
 
Neutrophils and macrophages 
The number of septal neutrophils was similar in IL-1β/β6+/+ and IL-1β/β6-/- mice. However, 
the IL-1β-induced transepithelial migration of neutrophils from lung parenchyma to alveolar 
spaces was suppressed in β6-deficient mice. The production of KC and MIP-2, essential for 
maximal neutrophil emigration into the alveolar spaces (Frevert et al., 1995; Schmal et al., 
1996), was inhibited in mice lacking the β6 integrin subunit. Blocking S100A8 and S100A9 
inhibits the migration of neutrophils and macrophages into the alveolar spaces during 
Streptococcal pneumonia (Raquil et al., 2008). Possibly the lower expression of these 
calgranulins in β6-/- mice might have reduced the IL-1β-induced transepithelial migration of 
neutrophils into the airspaces.  
 
Preterm infants developing BPD have elevated levels of chemokines and inflammatory cells 
in tracheal aspirate fluid soon after delivery and inflammation is thought to be an important 
contributing factor in lung injury observed in these infants (Speer, 2006). Absence of the β6 
integrin subunit suppressed the IL-1β-induced infiltration of macrophages into the lung 
parenchyma and the alveolar spaces, despite increased expression of the monocyte 
chemoattractants MCP-1 and MCP-3 compared to IL-1β/β6+/+ mice. However, the expression 
of SAA3, S100A8, and S100A9 and the production of osteopontin were reduced in IL-1β/β6-/- 
mice compared to IL-1β/β6+/+ mice. Since these proteins are chemotactic for e.g. monocytes 
and macrophages (Liang et al., 2000; O'Regan, 2003; Raquil et al., 2008), the decreased 
production of these proteins in IL-1β/β6-/- mice may have resulted in a less pronounced influx 
of macrophages into the lungs. Decreased IL-1β-induced infiltration of neutrophils into the 
alveolar spaces of β6-/- mice may have contributed to the lower number of macrophages in the 
lungs of IL-1β/β6-/- mice, since neutrophil infiltration may be important for the subsequent 
increase in lung monocytes/macrophages (Janardhan et al., 2006).  
 
Spontaneous inflammation in β6-/- mice 
Adult mice lacking the β6 integrin subunit are protected from bleomycin-induced ALI 
(Munger et al., 1999; Pittet et al., 2001). Pittet et al. suggested that the spontaneous 
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inflammation observed in adult β6-/- mice (Huang et al., 1996) may condition their lungs to 
resist subsequent bleomycin-induced lung injury (Pittet et al., 2001). A spontaneous 
inflammation was detected in control/β6-/- pups in the present study. At PN7, control/β6-/- 
mice had more alveolar neutrophils and higher expression of several chemokines (i.e. KC, 
MIP-2, MCP-1, MCP-3, S100A8 and S100A9) than control/β6+/+ mice. However, at E14, the 
time point at which the production of hIL-1β first becomes induced in the lungs of 
bitransgenic mice, the levels of inflammatory cytokines and inflammatory cells were not 
higher in β6-/- fetuses compared to β6+/+ fetuses. Thus, the partial protection to IL-1β-induced 
inflammation and injury observed in β6-/- infant mice is probably not due to a tolerance of 
inflammatory injury due to a previous inflammation.  
 
Airway structure 
The airways of control/β6-/- pups were similar to those of control/β6+/+ pups and did not 
display goblet cell hyperplasia. The chitinase-like lectins Ym1 and Ym2 are upregulated in 
allergic airway inflammation and may play a role in the development of asthma (Iwashita et 
al., 2006; Webb et al., 2001). Absence of the β6 integrin subunit strongly suppressed the IL-
1β-induced expression of Ym1 and Ym2 and reduced goblet cell hyperplasia. In addition to 
the chemoattractant role of osteopontin, it has recently been suggested that osteopontin is an 
important factor in promoting the development of asthma in adult mice (Kohan et al., 2009). 
Osteopontin deficiency resulted in a reduced number of mucus-producing airway cells (goblet 
cells) and a reduced number of leukocytes recovered in BAL fluid in a mouse model of 
chronic allergen-induced asthma (Kohan et al., 2009). It is possibly that inhibition of Ym1, 
Ym2 and osteopontin by the absence of the β6 integrin subunit may have in part prevented the 
IL-1β-induced airway inflammation and remodeling.  
 
TGF-β1 in pulmonary disease 
The αvβ6 integrin is an activator of TGF-β1. IL-1β increased the levels of active TGF-β1, but 
there was no significant difference in the levels of active TGF-β1 in the lungs of IL-1β/β6+/+ 
mice and IL-1β/β6-/- mice, consistent with other studies (Ludlow et al., 2005; Munger et al., 
1999). Since the binding of latent TGF-β1 to the αvβ6 integrin causes a conformational 
change in the TGF-β1 complex without causing release of free TGF-β, it is believed that lack 
of the β6 integrin subunit results in a local deficiency of active TGF-β1 (Munger et al., 1999; 
Sheppard, 2003). This local decrease in TGF-β1 might be difficult to detect in whole lung 
homogenates. The protective effect of β6 integrin deficiency in lung fibrosis of adult mice is 
thought to be a consequence of local decrease in TGF-β1 (Munger et al., 1999). Both IL-1β in 
the present model and the αvβ6 integrin are expressed solely in epithelial cells. The protection 
against IL-1β-induced lung injury in β6-/- mice might be a result of local inhibition of TGF-β1 
activity. Recently, IL-1β-induced increase in vascular permeability and edema in adult mice 
were shown to be partially dependent on αvβ6 integrin and/or TGF-β signaling (Ganter et al., 
2008). Inhibition of the αvβ6 integrin or TGF-β blocks the IL-1β-induced increase in vascular 
permeability across epithelial monolayers in vitro (Ganter et al., 2008).  
 
Preterm infants developing BPD have increased levels of active TGF-β1 in their lungs 
(Kotecha et al., 1996a; Lecart et al., 2000). Overexpression of TGF-β1 disrupts lung 
development prior to birth (Zhou et al., 1996b), and when it occurs from PN7, TGF-β1 causes 
an illness in the lungs of young mice characterized by few alveoli, thick alveolar septa, 
abnormal vascular appearance, and fibrosis (Vicencio et al., 2004). On the other hand, 
inhibition of TGF-β1 signaling partially protects against hypoxia- or hyperoxia-induced lung 
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injury in newborn mice (Ambalavanan et al., 2008; Nakanishi et al., 2007). The role of TGF-
β1 in the present mouse model of BPD remains to be determined. The αvβ6 integrin can also 
bind fibronectin (Busk et al., 1992; Weinacker et al., 1994), vitronectin (Huang et al., 1998a), 
tenascin (Prieto et al., 1993; Yokosaki et al., 1996) and osteopontin (Yokosaki et al., 2005) 
and may therefore affect the lung by interacting with other proteins than TGF-β1. 
 
A possible protective role of MMP-9 in BPD 
Increased levels of MMP-9 and an imbalance between MMP-9 and its inhibitor TIMP-1 have 
been associated with the development of BPD in infants (Ekekezie et al., 2004; Fukunaga et 
al., 2009; Schulz et al., 2004) and in animals models (Tambunting, et al., 2005). Blocking 
MMP has been suggested as a potential therapeutic target in BPD (Chetty et al., 2008; 
Ekekezie et al., 2004). However, other studies have not demonstrated an increase in MMP-9 
activity in BPD infants compared to non-BPD infants (Cederqvist et al., 2001; Danan et al., 
2002). Elevated MMP-9 activity has been correlated with the recovery from RDS in preterm 
infants, whereas infants who developed BPD did not have elevated MMP-9 activity (Dik et 
al., 2006). The role of MMP-9 in the development of BPD is unclear and difficult to study in 
the human infant.  
Alveolarization 
We studied the lung development in IL-1β-expressing and control mice with wild-type or null 
MMP-9 loci. Since control/MMP-9-/- mice had normal alveolar development, MMP-9 is not 
essential for normal alveolar development. In the present animal model of BPD, IL-1β 
increased the expression and activity of MMP-9. Absence of MMP-9 however, did not 
improve the IL-1β-induced lung injury. Instead lack of MMP-9 worsened the alveolar 
hypoplasia in IL-1β-expressing newborn mice, suggesting that MMP-9 has a protective role in 
inflammatory lung injury. Decreased (Hosford et al., 2004) and increased (Cederqvist et al., 
2006) levels of MMP-9 have been associated with hyperoxia-induced lung injury in animal 
models. MMP-9 deficiency worsens ventilator-induced injury in adult mice (Albaiceta et al., 
2008). In contrast, Chetty et al. demonstrated that absence of MMP-9 alleviates hyperoxia-
induced lung injury in newborn mice (Chetty et al., 2008). The hIL-1β transgene in the 
present model of BPD is induced during gestation (Bry et al., 2007), whereas mice in the 
study by Chetty et al. (2008) were exposed to hyperoxia from PN5 to PN13, i.e. after the 
beginning of alveolarization. Possibly, the increased production of MMP-9 during IL-1β-
induced lung injury is part of a repair process and thus lack of MMP-9 aggravates the induced 
injury. MMP-9 may have diverse roles in different types of pulmonary injury caused by 
different insults and at different times during development. 
 
MMP-9 during repair of injured epithelium  
In the CCSP-controlled transgenic mouse model of BPD, the expression of IL-1β, restricted to 
epithelial cells, is likely to cause injury to epithelial and adjacent cells. After an injury to the 
epithelium, the epithelial cells at the edge of the wound spread, proliferate, and migrate to 
cover the de-epithelialized zone. Both the pro-form and the active form of MMP-9 are 
expressed in human bronchial epithelial cells during repair (Buisson et al., 1996). After 
wound injury, MMP-9 accumulates in migrating airway epithelial cells and promotes the 
migration of these cells in vitro (Legrand et al., 1999). Activation of MMP-9 is likewise 
associated with increased migration of hyperoxia-exposed alveolar epithelial cells (Buckley et 
al., 2001). It is possible that the MMP-9 activity present in IL-1β/MMP-9+/+ lungs participates 
in a repair process initiated as a consequence of the IL-1β-induced lung injury. 
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MMP-9 and inflammation 
MMP-9 has been shown to participate in the migration of neutrophils (Keck et al., 2002; Kim 
et al., 2006) and can affect the activity of chemokines (Atkinson and Senior, 2003; 
Chakrabarti and Patel, 2005; Van den Steen et al., 2000). Absence of MMP-9 did not 
modulate the number of lung neutrophils at PN4 or PN7 in control mice. IL-1β increased the 
number of neutrophils and macrophages similarly in IL-1β/MMP-9+/+ and IL-1β/MMP-9-/- 
mice at PN4. However, at PN7, the number of neutrophils was lower IL-1β/MMP-9-/- than in 
IL-1β/MMP-9+/+ mice. Absence of MMP-9 increased the IL-1β-induced macrophage 
infiltration at PN7. This may have been caused by higher levels of chemoattractants. In 
addition, the increased number of apoptotic cells in IL-1β/MMP-9-/- mice may have 
stimulated infiltration of macrophages into the lungs of these mice (Savill et al., 1989; Wang 
et al., 2003).  
 
Antenatal inflammation, surfactant, and lung injury 
The presence of inflammatory mediators in the lung soon after birth suggests that 
inflammation promoting lung injury in premature infants may begin before birth (Murthy and 
Kennea, 2007). Watterberg et al. suggested that newborn infants exposed to chorioamnionitis 
are protected from RDS but have an increased risk of developing BPD (Watterberg et al., 
1996). These correlations between chorioamnionitis and RDS or BPD have been confirmed 
by other, but not all studies (Been and Zimmermann, 2009). A single intra-amniotic injection 
of IL-1 (Bry et al., 1997; Willet et al., 2002) or endotoxin (Jobe et al., 2000; Kramer et al., 
2001) enhances the production of surfactant components, e.g. SP-B, and improves lung 
function after preterm delivery. The acute effects of IL-1α on the lung surfactant system 
studied in rabbit lung explants in vitro are dependent on degree of lung maturity (Glumoff et 
al., 2000).  
 
Since intrauterine infections such as chorioamnionitis are often chronic (Goldenberg et al., 
2000; Wenstrom et al., 1998), we sought to determine how a prolonged continuous fetal 
expression of hIL-1β mainly in type II epithelial cells affects lung development (Paper III). 
Induced expression of IL-1β under the control of the SP-C promoter disrupted acinar bud 
formation as demonstrated by fewer distal airspaces occupying a smaller area of the distal 
lung. IL-1β decreased the production of SP-B, pro-SP-C and CCSP, suggesting that the 
differentiation of distal and proximal lung epithelial cells was affected (Clark et al., 2001; 
Harrod et al., 1998; Lin et al., 1999; Zeng et al., 1998; Zhou et al., 1996a). As an indication 
of severe lung injury, none of the IL-1β-expressing mice survived beyond PN1. Production of 
lung surfactant is necessary for postnatal survival. Mice lacking SP-B die immediately after 
birth (Clark et al., 1995). Since the lungs of IL-1β-expressing fetuses had decreased 
expression of SP-B and fewer SP-B-positive cells, SP-B deficiency may have contributed to 
the neonatal mortality in these mice. Chronic inflammation may have a more serious effect on 
surfactant production and lung development than a single exposure to IL-1β.  
 
Transgenic expression of IL-1β, controlled by the SP-C or CCSP promoter 
In Papers I and II, the hIL-1β transgene is expressed under the control of the CCSP promoter, 
whereas IL-1β in Paper III is under the control of the SP-C promoter. Bry et al. previously 
demonstrated that CCSP-controlled IL-1β expression disrupts alveolar and vascular 
development in newborn mice, thereby causing a lung disease that resembles BPD (Bry et al., 
2007). This was confirmed in both Paper I and Paper II. However, the mice appear healthy at 
birth and do not have disrupted acinar bud formation or inhibited surfactant protein expression 
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prior to birth (unpublished data) as IL-1β-expressing SP-C mice do. When doxycycline is 
administered to pregnant dams, the expression of IL-1β is initiated in bitransgenic CCSP-
rtTA/(tetO)7-CMV-hIL-1β mice at ~E14 (Bry et al., 2007) whereas target transgene 
expression in SP-C-rtTA/(tetO)7-CMV-hIL-1β starts at ~E11 (Perl et al., 2002). Previous 
studies have shown that the target transgene controlled by the SP-C promoter is expressed in 
the epithelium of the distal lung but not in the proximal airways, whereas when controlled by 
the CCSP promoter the target transgene is detected in both the distal and proximal lung 
epithelium (Akeson et al., 2003; Perl et al., 2002; Perl et al., 2009). Possibly a more distal 
location of target transgene expression in the SP-C-rtTA/(tetO)7-CMV-hIL-1β mice has led to 
the dissimilar fetal lung structure compared to CCSP-rtTA/(tetO)7-CMV-hIL-1β mice. The 
more severe phenotype of SP-C-rtTA/(tetO)7-CMV-hIL-1β mice may also be a consequence 
of the fact that the transgenic expression is induced earlier and is higher than in CCSP mice 
(Bry et al., 2007; Perl et al., 2002; Paper III). Differences in timing, concentration and 
location of IL-1β expression may result in different forms of lung disease.  
 
Apoptosis in inflammatory lung injury 
Apoptosis, programmed cell death, occurs normally during lung organogenesis and injury to 
remove old and damaged cells. Apoptosis of mesenchymal cells at the periphery of distal lung 
buds is detected during late embryonal lung development and increases at birth (Kresch et al., 
1998), but declines rapidly thereafter leading to a nadir around PN7 (Luyet et al., 2002). Both 
decreased and increased levels of apoptosis have been detected in the lungs of infants with 
RDS and infants developing BPD (Hargitai et al., 2001; Kotecha et al., 2003; Lukkarinen et 
al., 2003; Oei et al., 2003). Overexpression of FasL, an apoptosis inducer, disrupts 
alveolarization in mice (De Paepe et al., 2008). On the other hand, enhanced apoptosis of 
mesenchymal cells has been associated with improved alveolarization and thinning of 
airspace walls (Reyburn et al., 2008). Control/β6+/+ mice had a peak in apoptosis on PN0 that 
declined to PN7. In IL-1β/β6+/+ mice, apoptosis was reduced at PN0 but enhanced at PN7 
compared to control mice (Paper I). IL-1β/β6-/- and IL-1β/MMP-9-/- mice had at PN7 more 
apoptotic cells than IL-1β/β6+/+ and IL-1β/MMP-9+/+ mice, respectively, possibly contributing 
to the improved thinning of alveolar walls in β6-/- and MMP-9-/- mice. The disrupted lung 
development observed prenatally in SP-C promoter-controlled IL-1β-expressing mice was not 
associated with changes in the number of apoptotic cells in late gestation, suggesting that 
inflammation can arrest lung morphogenesis even in the absence of detectable changes in 
apoptosis.  
 
 37  
CONCLUSIONS 
 
Newborn mice lacking the β6 integrin subunit were partially protected from IL-1β-induced 
lung injury. IL-1β-expressing β6-/- mice had smaller alveoli, thinner alveolar septal walls, 
fewer macrophages and neutrophils in the alveolar spaces and decreased expression of several 
inflammatory mediators compared with IL-1β-expressing β6+/+ mice. In addition, mice 
lacking the β6 integrin subunit had a milder IL-1β-induced goblet cell hyperplasia in proximal 
airways. These results suggest for the first time that the β6 integrin subunit may play an 
important role in the development of BPD. 
 
Increased MMP-9 activity has been suggested to participate in the pathogenesis of BPD. Mice 
lacking MMP-9 developed a worse alveolar hypoplasia and an increased infiltration of 
macrophages in response to IL-1β expression than did MMP-9+/+ mice. The increased 
production of MMP-9 during inflammatory lung injury is not necessarily disadvantageous for 
the lung. Blocking MMP-9 activity, previously suggested as a potential treatment for infants 
developing BPD, may be harmful.  
 
IL-1 has been shown to acutely increase surfactant protein production in premature animals. 
The effects of chronic IL-1β exposure on prenatal lung development and surfactant 
production have not been studied previously. Chronic expression of IL-1β, controlled by the 
SP-C promoter, caused a severe prenatal lung injury associated with decreased production of 
surfactant proteins, leading to 100% mortality at birth. These results suggest that chronic 
inflammation in the distal lung epithelium severely disrupts lung development and function. 
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FUTURE STUDIES 
 
Role of TGF-β1 in IL-1β-induced lung injury 
Since the αvβ6 integrin is an activator of the cytokine TGF-β1, some differences between IL-
1β/β6-/- mice and IL-1β/β6+/+ mice may be caused by a local deficiency of TGF-β in mice 
lacking the β6 integrin subunit. However, the β6 integrin binds other proteins as well and may 
have unidentified roles in pulmonary diseases. Thus, it would be of interest to investigate 
whether the improved phenotype in IL-1β/β6-/- mice compared to IL-1β/β6+/+ mice is caused 
by diminished TGF-β1 activity. Projected experiments where IL-1β-expressing wild-type 
mice are injected with prenatal and/or postnatal antibodies inhibiting TGF-β signaling will 
study whether inhibition of TGF-β1 activity improves lung development in IL-1β-expressing 
mice.  
 
Long-term effects of perinatal IL-1β expression 
Children with BPD have an enhanced risk of asthma and may have abnormal lung function 
until adulthood (Doyle et al., 2006; Wong et al., 2008; Vrijlandt et al., 2005; Vrijlandt et al., 
2007). Preliminary data using the SP-C transgenic model demonstrate that cessation of 
doxycycline administration to the pregnant dam at 16 days after vaginal plug (i.e. the fetuses 
are embryonal day 16) does not cause neonatal mortality of bitransgenic SP-C-rtTA/(tetO)7-
CMV-hIL-1β pups. These IL-1β-expressing mice survive at least until PN7 despite structural 
changes in the distal lung observed postnatally. Using this model it is possible to study how 
prenatal inflammation affects lung structure and function in adulthood.  
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